RDGL Company Profile and Key Details

Q: Who are the executives of RDGL?

Dr. Michael K. Korenko Ph.D.Chief Executive Officer, Pres & DirectorDr. Fu-Min SuChief Radio Chemist & Radiation Safety OfficerDr. David J. Swanberg M.S., P.E.Chief Technical Mang.Dr. Nigel R. Stevenson B.Sc., Ph.D.Chief Science OfficerDr. Carlton M. Cadwell D.D.S.Independent Chairman & Sec.

PNK : RDGL

Vivos

$0.18

0.0098+5.76%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Vivos Inc. (RDGL) stock surged +0.64%, trading at $0.06 on OTC, up from the previous close of $0.06. The stock opened at $0.06, fluctuating between $0.06 and $0.06 in the recent session.

Stock Snapshot

0.0629

Prev. Close

30.55M

Market Cap

0.0612

Day Low

-6.33

P/E Ratio

-0.01

EPS (TTM)

Cash Flow per Share

0.06

Open

482.69M

Number of Shares

0.0643

Day High

95.55%

Free Float in %

Book Value

3.33M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 11, 2026	0.06	0.06	0.06	0.06	5.54M
May 08, 2026	0.07	0.07	0.06	0.06	2.91M
May 07, 2026	0.07	0.07	0.07	0.07	1.55M
May 06, 2026	0.07	0.07	0.07	0.07	3.79M
May 05, 2026	0.07	0.07	0.07	0.07	307.77K
May 04, 2026	0.07	0.07	0.06	0.07	2.02M
Apr 30, 2026	0.07	0.07	0.07	0.07	1.16M
Apr 29, 2026	0.07	0.07	0.07	0.07	1.86M
Apr 28, 2026	0.07	0.07	0.07	0.07	4.47M
Apr 27, 2026	0.07	0.07	0.07	0.07	2.54M
Apr 23, 2026	0.07	0.08	0.07	0.07	298.01K
Apr 22, 2026	0.07	0.08	0.07	0.07	3.86M
Apr 21, 2026	0.07	0.07	0.07	0.07	152.08K
Apr 20, 2026	0.07	0.07	0.07	0.07	2.83M
Apr 17, 2026	0.07	0.07	0.07	0.07	2.71M
Apr 16, 2026	0.07	0.08	0.07	0.07	4.57M
Apr 14, 2026	0.08	0.08	0.07	0.07	1.18M
Apr 13, 2026	0.08	0.08	0.07	0.08	692.76K
Apr 10, 2026	0.08	0.08	0.08	0.08	4.06M
Apr 09, 2026	0.08	0.08	0.08	0.08	4.69M

Contact Details

Kennewick, WA 99352

United States

https://www.radiogel.com 509 736 4000

About Company

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Stock Peers

SONVF

Sonova Holding AG$321.70 CHEOF

Cochlear Limited$205.50 CHEOY

-0.98-0.89%

Cochlear Limited$108.73 GNNDY

GN Store Nord A/S$91.91 SONVY

0.11+0.17%

Sonova Holding AG$63.73 SEMHF

Siemens Healthineers AG$58.50 WILLF

Demant A/S$45.88 XVIPF

-0.33-0.77%

Xvivo Perfusion AB (publ)$42.76 SMMNY

-0.43-1.46%

Siemens Healthineers AG$29.03 RYLPF

Koninklijke Philips N.V.$27.15

Company Overview

The stock is currently mid-range between its 52-week high and low $0.04 and $0.15. With a market capitalization of about $30.55 million, Vivos Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.76). Key stats such as the average daily volume over the past year has been around 1.33 million shares, trading with heavier-than-usual volume. Headquartered in Kennewick, WA, Vivos Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Michael K. Korenko, the company employs approximately 1 people and listed since September 02, 1998. Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors.

Technical Performance

Average 10-day trading volume of 2.69 million shares is significantly above the 3-month average of 1.26 million, indicating heightened recent market interest.

Valuation Metrics

Vivos Inc. trades at a P/E ratio of -9.33, slightly below the S&P 500 average, with a price-to-sales ratio of 446.13 and a price-to-book ratio of 17.23 reflecting a rich premium to book value. The P/FCF stands at -14.12, also below market averages. Compared to sector medians, Vivos Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Vivos Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.04. This means the shares are trading below this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Vivos generated $19.50K in revenue, or $0.00 per share. Gross margin was -1475.65%, operating margin -14323.85%, and net profit margin -14844.89%. Returns are negative, with ROA at -179.78% and ROE at -212.05%.
On valuation metrics, Vivos trades at a P/E of -9.33, P/S of 446.13 and P/B of 17.23. The current ratio is 14.00 and quick ratio is 13.52. Operationally, the company’s inventory turnover is 2.24 and cash conversion cycle is 18.89 days. Debt-to-equity is 0.07, supported by a cash flow-to-debt ratio of -18.01.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Vivos posted revenue of $19.50K, down slightly from $36.50K in the prior quarter. Gross profit was - $287.75K (margin -1475.65%). Operating income was - $2.79M (margin -14323.8%). Net income was- $2.89M (EPS - $0.01).
The company ended the quarter with $1.59M in cash and short-term investments, a total debt of $0.00, and net debt of - $1.59M. Total assets were $1.61M, with equity of $1.37M. Financials further reflected weakness, with operating cash flow of - $1.29M, free cash flow of - $1.29M, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Vivos Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Vivos Inc. trading at a premium to the broader market with a P/E of -9.33.

Frequently Asked Questions

What is the current Vivos Inc. (RDGL) stock price?

Vivos Inc. (OTC: RDGL) stock price is $0.06 in the last trading session. During the trading session, RDGL stock reached the peak price of $0.06 while $0.06 was the lowest point it dropped to. The percentage change in RDGL stock occurred in the recent session was 0.64% while the dollar amount for the price change in RDGL stock was $0.00.

RDGL's industry and sector of operation?

The OTC listed RDGL is part of Medical - Devices industry that operates in the broader Healthcare sector. Vivos Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RDGL?

Dr. Michael K. Korenko Ph.D.
Chief Executive Officer, Pres & Director
Dr. Fu-Min Su
Chief Radio Chemist & Radiation Safety Officer
Dr. David J. Swanberg M.S., P.E.
Chief Technical Mang.
Dr. Nigel R. Stevenson B.Sc., Ph.D.
Chief Science Officer
Dr. Carlton M. Cadwell D.D.S.
Independent Chairman & Sec.

How RDGL did perform over past 52-week?

RDGL's closing price is 337% higher than its 52-week low of $0.04 where as its distance from 52-week high of $0.15 is -25.62%.

How many employees does RDGL have?

Number of RDGL employees currently stands at 1.

Link for RDGL official website?

Official Website of RDGL is: https://www.radiogel.com

How do I contact RDGL?

RDGL could be contacted at phone 509 736 4000 and can also be accessed through its website. RDGL operates from 719 Jadwin Avenue, Kennewick, WA 99352, United States.

How many shares of RDGL are traded daily?

RDGL stock volume for the day was 3.33M shares. The average number of RDGL shares traded daily for last 3 months was 1.33M.

What is the market cap of RDGL currently?

The market value of RDGL currently stands at $30.55M with its latest stock price at $0.06 and 482.69M of its shares outstanding.

Employees	1
Beta	-0.64
Sales or Revenue	$19.50K
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

RDGL Company Profile and Key Details

Vivos

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Company Overview

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics